Advertisement
Home2024-01-11T09:26:42-05:00

Top Story

  • Small particles grouped into transparent bubbles
    Health Policy

    Aerial Contagion: Redefining Airborne Pathogens

    April 25th, 2024

    ⁤The World Health Organization (WHO) has recently announced a revision of its classification of airborne pathogens, including SARS-CoV-2, after criticism of delayed recognition during the pandemic. ⁤⁤The WHO's technical report replaces the previous three categories of viral transmission airborne, droplet, and aerosol, with "infectious respiratory particles". [...]

Latest Stories

HEOR

RWE

Market Access

Advertisement

Featured Webinars

Handpicked Promotions & Highlights

Latest in Catalyst News powered by BioPharmCatalyst

04/24/2024 04:44 PM ET

Cyclacel Pharmaceuticals TNXP date announcement

Tonix Pharmaceuticals Holding now has three catalyst announcements on the calendar after revealing the date on which they will release trial results for Tonmya (TNX-102 SL) - (RELIEF/RESILIENT). Tonix Pharmaceuticals Holding plans to announce top-line [...]

Read More
04/24/2024 04:44 PM ET

Immutep Limited IMMP date announcement

Immutep Limited has an announcement scheduled for June 30, 2024 regarding their recent Phase 2b trial of Eftilagimod alpha (IMP321) and KEYTRUDA (pembrolizumab) - (TACTI-003). Our predictive system gives the drug a 33.7% chance of [...]

Read More
04/24/2024 04:44 PM ET

Innoviva INVA date announcement

Innoviva plans to announce top-line results for their NDA Filing trial of Zoliflodacin on March 31, 2025. Our calculations show a 66.4% chance that the drug makes it to the next stage.

The announcement didn’t [...]

Read More
04/24/2024 04:44 PM ET

Affimed N.V. AFMD date announcement

Affimed N.V. now has four catalyst announcements on the calendar after revealing the date on which they will release trial results for AFM24-102 and TECENTRIQ (atezolizumab). Now that the Phase 1/2 trial is completed, Affimed [...]

Read More

Search HealthEconomics.com

Throw in a keyword, research topic, disease model or technology of interest

Latest From Our Blog

Receive essential insights, resources and content direct to your inbox

Hit subscribe to stay informed!

Quick Links

Our Company

Privacy Policy

Advertising & Marketing Services


ABOUT US

HealthEconomics.com is the world’s largest digital Connected Community™ for Value, Evidence and Access in the life sciences industry. HealthEconomics.com provides professionals within the health economic and outcomes research (HEOR), real-world evidence (RWE) and Market Access (MA) communities a single global link to industry insights and news, market reports and more. Since the beginning, we have provided unparalleled access to help our stakeholders drive business, improve knowledge and connect researchers and payer decision-makers worldwide.

SCIENTIST.COM FAMILY

Scientist.com is a privately-held, San Diego-based company on a mission to empower and connect scientists and make it faster and cheaper to discover new medicines. At its heart is an AI-powered marketplace for complex research experiments with the potential to transform the pharmaceutical industry in the same way Amazon has transformed the retail industry. The marketplace helps drug researchers use innovative technologies to rapidly translate their ideas into actionable data. Scientist.com’s clients include most of the world’s largest pharmaceutical companies, 100+ biotechs and the US National Institutes of Health. Through Scientist.com, these clients communicate directly with research experts at over 4,000 global laboratories to design and execute complex research experiments.

Learn more at Scientist.com.

© Copyright | HealthEconomics.Com - A Scientist.com Company | All Rights Reserved
LinkedInTwitterFacebookVimeo
Cookies help us deliver our services and optimize website experience. By continuing to browse this domain, you accept our terms and conditions and privacy policy. Read our privacy policy Accept
Go to Top